Fast monolithic micellar liquid chromatography: An alternative drug permeability assessing method for high-throughput screening

Analytical Chemistry

Volumn 76, Issue 24, 2004, Pages 7304-7309

  Detroyer, A ^a   Stokbroekx, S ^b   Bohets, H ^b   Lorreyne, W ^b   Timmerman, P ^b   Verboven, P ^b   Massart, D L ^a   Vander Heyden, Y ^a  

^a PHARMACEUTICAL INSTITUTE   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; DRUG PRODUCTS; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; MECHANICAL PERMEABILITY; SCREENING;

BIOLOGICAL ACTIVITY; HYDROPHOBIC INTERACTIONS; MONOLITHIC MICELLAR LIQUID CHROMATOGRAPHY; ORAL DRUGS;

MICELLES;

ARTICLE; CELL STRAIN CACO 2; DRUG ABSORPTION; DRUG PENETRATION; HIGH THROUGHPUT SCREENING; HYDROPHOBICITY; INTESTINE ABSORPTION; LIQUID CHROMATOGRAPHY; MICELLAR LIQUID CHROMATOGRAPHY;

CACO-2 CELLS; CHROMATOGRAPHY, LIQUID; HUMANS; HYDROPHOBICITY; INTESTINAL ABSORPTION; MEMBRANES, ARTIFICIAL; MICELLES; PERMEABILITY; PHARMACEUTICAL PREPARATIONS;

EID: 10644257679     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac048944k     Document Type: Article

References (25)

1. Bohets, H.; Annaert, P.; Mannens, G.; Van Beijsterveldt, L.; Anciaux, K.; Verboven, P.; Meuldermans, W.; Lavrijsen, K. Curr. Top. Med. Chem. 2001, 1, 367-83.
2. Bleicher, K. H.; Bohm, H. J.; Muller, K.; Alanine, A. I. Nat. Rev. Drug Discovery 2003, 2, 369-378.
3. Artursson, P.; Karlsson, J. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
4. Lenneras, H. J. Pharm. Pharmacol. 1997, 49, 7, 627-638.
5. Hidalgo, I. J. Curr. Top. Med. Chem. 2001, 1, 385-401.
6. Flyn, G. L.; Yalkowski, S. H. J. Pharm. Sci. 1972, 63, 838-852.
7. OECD guideline to test chemical products 107, partition coefficient (n-octanol/water), shake flask method; OECD, Paris, France, 1981.
8. Harnisch, M.; Möckel, H. J.; Schulze, G. J. Chromatogr. 1983, 282, 315-332.
9. Valkó, K. J. Liq. Chromatogr. 1984, 7, 1405-1424.
10. Nasal, A.; Siluk, D.; Kaliszan, R. Curr. Med. Chem., 2003, 10, 381-426.
11. Rekker, R. F. The hydrofobic fragmental constant: Pharmacochemistry Library; Elsevier: New York, 1977.
12. Hansch, C.; Leo, A. Exploring QSAR, Fundamentals and Applications in Chemistry and Biology; American Chemical Society: Washington, DC, 1995.
13. Woodrow, B. N.; Dorsey, J. G. Environ. Sci. Technol. 1997, 31, 2812-2820.
14. Kansy, M.; Senner, F.; Gubernator, K. J. Med. Chem. 1998, 41, 1007-1010.
15. Armstrong, D. W.; Nome, F. Anal. Chem. 1981, 53, 1662-1666.
16. Berthod, A.; García-Alvarez-Coque, M. C. Micellar Liquid Chromatography; Marcel Dekker, New York, 2000.
17. Tanford, C. The Hydrophobic Effect: Formation of Micelles and Biological Membranes, 2nd ed.; Wiley: New York, 1980.
18. Detroyer, A.; Vander Heyden, Y.; Carda-Broch, S.; García-Alvarez- Coque, M. C.; Massart, D. L. J. Chromatogr., A 2001, 972, 211-221.
19. García-Alvarez-Coque, M. C.; Torres Lapasió, J. R. Trends Anal. Chem. 1999, 18, 8, 533-543.
20. Detroyer, A.; Vander Heyden, Y.; Reynaert, K.; Massart, D. L. Anal. Chem. 2004, 76, 1903-1908.
21. http://esc_plaza.syrres.com/interkow/kowdemo.htm.
22. Artursson, P.; Karlsson, J. Biochem. Biophys. Res. Commun. 1991, 175, 3, 880-885.
23. Ren, S.; Lien, E. J. Prog. Drug Res. 2000, 54, 1-23.
24. Wessel, M. D.; Jurs, P. C.; Tolan, J. W.; Muskal, S. M. J. Chem. Inf. Comput. Sci. 1998, 38, 726-735.
25. Waver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage froms based on a biopharmaceutics classification system; FDA, CDER, Rockville, MD, 2001.